According to South Korean media NEWSWIRE, on May 23rd, a gene editing and repair company called ToolGen, based in Seoul, signed a joint development agreement with the South Korean tobacco manufacturing and sales company KT&G to develop a high value-added tobacco correction system. The agreement is set to take effect on May 23, 2024.
The main purpose of this agreement is to develop new varieties of tobacco with specific reduced components and excellent taste using gene editing technology.
ToolGen's representative, Lee Byunghwa, stated, "ToolGen is utilizing gene editing technology to develop high-value seeds. We have obtained a biotechnology crop regulation exemption permit from the United States Department of Agriculture (USDA) for genetically repaired dwarf morning glory, soybeans, potatoes, etc., proving that we possess the highest level of technological capabilities globally. The two companies will engage in mutually beneficial cooperation in areas such as joint research, academic exchanges, and shared use of research equipment and facilities.
In addition, the agreement also stipulates that both parties will work together to develop new genetic resources and cultivate new varieties, and commercialize these new varieties.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
